CUSIP 142038108COMCRBUQ4 2025
31 filings · latest Jul 16, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Pfizer Inc | 4.69M | $7.46M |
| 2 | Vanguard Group Inc | 4.30M | $6.84M |
| 3 | Kynam Capital Management, LP | 2.50M | $3.98M |
| 4 | Blackrock, Inc. | 2.14M | $3.40M |
| 5 | Renaissance Technologies LLC | 1.64M | $2.61M |
| 6 | Aberdeen Group PLC | 1.39M | $2.21M |
| 7 | Two Sigma Advisers, LP | 1.12M | $1.77M |
| 8 | Susquehanna International Group, LLP | 1.03M | $1.64M |
| 9 |
| 4 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 6.8% | 6.28M | SEC |
| 5 | Feb 14, 2025 | Bank Of America Corp /De/ | 13G/A | 2.2% | 1.95M | SEC |
| 6 | Dec 6, 2024 | Haurwitz Rachel E. | 13D/A | 3.7% | 3.35M | SEC |
| 7 | Nov 14, 2024 | Pfm Health Sciences, LP | 13G/A | 4.8% | — | SEC |
| 8 | Nov 14, 2024 | Avidity Partners Management LP | 13G/A | — | — | SEC |
| 9 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | 2.5% | 2.24M | SEC |
| 10 | Nov 14, 2024 | Bank Of America Corp /De/ | 13G | 5.6% | 5.05M | SEC |
See the full Schedule 13D/13G history for Caribou Biosciences Inc.
Unlock full history| 1.02M |
| $1.62M |
| 10 | Dimensional Fund Advisors LP | 1.01M | $1.60M |